ISB News

Biomedical Pioneer: Dr. Leroy Hood

Dr. Leroy Hood, ISB's president and co-founder, was featured in this Q&A in Medgadget:

"If you are involved in biomedical research you have almost certainly used a device or technique developed by Leroy Hood. The most notable among his innovations include the automated DNA sequencer and synthesizer as well as the automated protein sequencer and synthesizer. For his work on these four instruments – cornerstones of modern molecular biology – Dr. Hood was awarded the American and Japanese equivalents of the Nobel Prize: the Lasker Award and Kyoto Prize. Throughout his career he has successfully translated his basic science research from bench-to-bedside by co-founding more than 14 companies, including Amgen and Applied Biosystems."

Recent Articles

  • ISB Associate Professor Dr. Sean Gibbons

    ‘1 in 1,000:’ Dr. Sean Gibbons Named Highly Cited Researcher for 2023

    ISB Associate Professor Dr. Sean Gibbons was named a Highly Cited Researcher for 2023. It is the second consecutive year Gibbons has earned the distinction. The Highly Cited Research list is generated annually by Clarivate, which says: “Of the world’s population of scientists and social scientists, Highly Cited Researchers are 1 in 1,000.”

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on.

  • Breakthrough T Cell Discovery Has Huge Potential for Engineering Custom Immune Responses

    In a breakthrough discovery that changes how we understand T cells and with implications of how we can better engineer custom immune responses to fight disease, Institute for Systems Biology researchers showed that the different disease-fighting functions of different T cells are determined by the genetically encoded T-cell receptor sequence that are unique to those cells.